(1.02%) 5 099.96 points
(0.40%) 38 240 points
(2.03%) 15 928 points
(0.11%) $83.66
(-3.32%) $1.920
(0.30%) $2 349.60
(-0.43%) $27.52
(0.42%) $924.40
(0.32%) $0.935
(0.67%) $11.02
(0.13%) $0.800
(-0.07%) $92.11
Live Chart Being Loaded With Signals
EyeGate Pharmaceuticals, Inc. is a clinical stage specialty pharmaceutical company, which engages in the development and commercialization of products for treating diseases and disorders of the eye...
Stats | |
---|---|
Šios dienos apimtis | 10 000.00 |
Vidutinė apimtis | 469.00 |
Rinkos kapitalizacija | 64.23M |
EPS | $-0.420 ( 2021-11-08 ) |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -19.65 |
ATR14 | $0 (0.00%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2021-11-02 | From Stephen | Sell | 250 | Common Stock |
2021-11-02 | Mann Brenda | Sell | 62 | Common Stock |
2021-10-04 | Mann Brenda | Sell | 62 | Common Stock |
2021-10-04 | From Stephen | Sell | 249 | Common Stock |
2021-09-02 | From Stephen | Sell | 253 | Common Stock |
INSIDER POWER |
---|
0.00 |
Last 98 transactions |
Buy: 1 959 813 | Sell: 207 057 |
EyeGate Pharmaceuticals Koreliacija
10 Labiausiai teigiamai susiję koreliacijos | |
---|---|
BMTC | 0.948 |
XPDI | 0.926 |
FATE | 0.912 |
TCDA | 0.908 |
GRAY | 0.905 |
ENPH | 0.896 |
BCAB | 0.895 |
ODT | 0.887 |
HECCU | 0.884 |
LHDX | 0.879 |
10 Labiausiai neigiamai susiję koreliacijos | |
---|---|
TIG | -0.936 |
CCRC | -0.928 |
FRGI | -0.917 |
ARNA | -0.903 |
DSPG | -0.899 |
ACIW | -0.899 |
NTES | -0.896 |
EXAS | -0.896 |
APEN | -0.896 |
GGAL | -0.895 |
Ar žinojote?
Koreliacija yra statistinis rodiklis, aprašantis ryšį tarp dviejų kintamųjų. Jis svyruoja nuo -1 iki 1, kur -1 reiškia tobulo neigiamo ryšio koreliaciją (padidėjus vienam kintamajam, sumažėja kitas), 1 reiškia tobulo teigiamo ryšio koreliaciją (padidėjus vienam kintamajam, padidėja ir kitas), o 0 reiškia jokios koreliacijos (tarp kintamųjų nėra jokio ryšio).
Koreliacija gali būti naudojama analizuojant bet kurių dviejų kintamųjų ryšį, ne tik akcijų. Jis dažnai naudojamas finansų, ekonomikos, psichologijos ir kitose srityse.
EyeGate Pharmaceuticals Finansinės ataskaitos
Annual | 2020 |
Pajamos: | $12 059.00 |
Bruto pelnas: | $12.06 (0.10 %) |
EPS: | $-2.54 |
FY | 2020 |
Pajamos: | $12 059.00 |
Bruto pelnas: | $12.06 (0.10 %) |
EPS: | $-2.54 |
FY | 2019 |
Pajamos: | $2.69M |
Bruto pelnas: | $0.00 (0.00 %) |
EPS: | $-2.23 |
FY | 2018 |
Pajamos: | $1.65M |
Bruto pelnas: | $0.00 (0.00 %) |
EPS: | $-4.50 |
Financial Reports:
No articles found.
EyeGate Pharmaceuticals
EyeGate Pharmaceuticals, Inc. is a clinical stage specialty pharmaceutical company, which engages in the development and commercialization of products for treating diseases and disorders of the eye. The company is headquartered in Waltham, Massachusetts and currently employs 11 full-time employees. The firm is focused on developing and commercializing therapeutics and drug delivery systems for treating diseases of the eye. The firm's lead product, EGP-437, incorporates a reformulated topically active corticosteroid, dexamethasone phosphate, which is delivered into the ocular tissues through its drug delivery system, the EyeGate II Delivery System. The firm is developing EGP-437 for the treatment of various inflammatory conditions of the eye, including uveitis, a debilitating form of intraocular inflammation of the anterior portion of the uvea, such as the iris and/or ciliary body, and macular edema, an abnormal thickening of the macula associated with the accumulation of excess fluids in the extracellular space of the neurosensory retina. The EyeGate II Delivery System is designed to deliver optimal quantities of drugs to the anterior or posterior segments of the eye.
Apie Signalai gyvai
Šiame puslapyje pateikti tiesioginiai signalai padeda nustatyti, kada PIRKTI ar PARDUOTI NA. Signalai vėluoja 1 minutę; kaip ir su visais rinkos signalais, taip ir su šiais, visuomet yra klaidų tikimybė.
Tiesioginiai prekybos signalai nėra apibrėžti, todėl getagraph.com neprisiima atsakomybės už jokius veiksmus, kurių buvo imtasi žinant šiuos signalus, kaip aprašyta Naudojimo sąlygose. Signalai yra pagrįsti įvairiais techninės analizės rodikliais.